Randomized control study to evaluate the efficacy of adjuvant androgen deprivation therapy after rotational IMRT in patients with high risk prostate cancer
- Conditions
- Prostate cancer
- Registration Number
- JPRN-UMIN000008887
- Lead Sponsor
- The University of Tokyo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Male
- Target Recruitment
- 200
Not provided
1.Clinical stage T3b or T4 2.Patients who has metastasis with lymph node or distant lesion 3.Patients with active another cancer 4.Patients with uncontrollable hypertension 5.Patients with severe psychiatric disorders 6.Patients with connective tissue disease 7.Patients with poorly controlled diabetes 8.Patients with poorly controlled ischemic heart disease 9.Patients who had prior surgery for prostate (e.g. radical prostatectomy) 10.Patients who had prior radiotherapy (e.g. EBRT, brachytherapy) 11.Patients who had prior orchiectomy 12.Patients who are treated with steroids (except for external use for skin) 13.Patients who are treated with anti-androgen for BPH 14.Patients who considered inappropriate for this trial by physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method